首页> 外文期刊>The Journal of molecular diagnostics: JMD >Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis
【24h】

Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis

机译:对血管肺泡灌洗液中两种商业实时PCR试剂盒进行两种商用实时PCR试剂盒,血液肺泡血液血液血液血液血液血液血管症患者

获取原文
获取原文并翻译 | 示例
       

摘要

Invasive pulmonary aspergillosis (IPA) is a common complication of immunosuppression. Rapid diagnosis using molecular techniques is essential to improve patient survival. PCR techniques are promising in enhancing Aspergillus detection in blood and respiratory samples. We evaluate for the first time the performances of two commercial real-time PCR kits, the A. fumigatus Bio-Evolution and the MycoGENIE A. fumigatus for the detection of A. fumigatus DNA in bronchoalveolar lavage (BAL) from patients with and without IPA. Seventy-three BAL samples were included. Thirty-one of them corresponded to patients with probable IPA, 11 to patients with possible IPA, and 31 to patients without aspergillosis, according to the 2008 European Organization for Research and Treatment of Cancer/Mycoses Study Group criteria. In the probable IPA group, A. fumigatus Bio-Evolution and the MycoGENIE A. fumigatus real-time PCR kits showed a specificity of 100% and a sensitivity of 81% and 71 %, respectively. The A. fumigatus Bio-Evolution detected Aspergillus DNA in the 14 BAL samples with a positive Aspergillus culture result, whereas the MycoGENIE A. fumigatus PCR result was positive only for 12. In the possible IPA group, there were no positive real-time PCR or positive Aspergillus culture results. For the patients without aspergillosis, no positive result was observed for real-time PCR kit, despite the presence of various other non-Aspergillus pathogens in this group. Our study demonstrates an excellent specificity and a good sensitivity of A. fumigatus DNA detection in BAL samples with both kits.
机译:侵袭性肺曲线症(IPA)是免疫抑制的常见并发症。使用分子技术的快速诊断对于改善患者存活至关重要。 PCR技术在提高血液和呼吸样品中的曲霉检测方面是有希望的。我们首次评估了两种商业实时PCR试剂盒的性能,A.Fumigatus生物进化和霉菌A. Fumigatus检测Hulcohoalveolar灌洗(BAL)的A. fumigatus DNA,来自有和没有IPA的患者。包括七十三个BAL样品。根据2008年欧洲研究和治疗组织癌症/玛科研究组标准的2008年欧洲研究和治疗组织的患者,其中31名患有可能的IPA的患者,11例,可能的IPA患者,31例,患者,没有曲霉病患者。在可能的IPA组中,A.Fumigatus生物进化和椎骨生物生物evolution A. Fumigatus实时PCR套件表现出100%的特异性和81%和71%的敏感性。 A. fumigatus生物进化检测到14个BAL样品中的曲霉病毒患者,染色毛细血管培养结果,而霉菌A. Fumigatus PCR结果仅为12.在可能的IPA组中,没有正实时PCR或正曲霉培养结果。对于没有曲柄症的患者,尽管存在在该组中存在各种其他非曲霉菌病原体,但仍未观察到实时PCR试剂盒的阳性结果。我们的研究表明,具有两种套件的BAL样品中A. Fumigatus DNA检测的优异特异性和良好的敏感性。

著录项

  • 来源
  • 作者单位

    Hop Univ Strasbourg Lab Parasitol &

    Mycol Med 1 Pl Hop F-67000 Strasbourg France;

    Hop Univ Strasbourg Lab Parasitol &

    Mycol Med 1 Pl Hop F-67000 Strasbourg France;

    Hop Univ Strasbourg Serv Oncol &

    Hematol Hop Hautepierre Strasbourg France;

    Hop Univ Strasbourg Serv Oncol &

    Hematol Hop Hautepierre Strasbourg France;

    CHU Strasbourg Pole Pathol Thorac Strasbourg France;

    Hop Univ Strasbourg Lab Parasitol &

    Mycol Med 1 Pl Hop F-67000 Strasbourg France;

    Hop Univ Strasbourg Lab Parasitol &

    Mycol Med 1 Pl Hop F-67000 Strasbourg France;

    Hop Univ Strasbourg Lab Parasitol &

    Mycol Med 1 Pl Hop F-67000 Strasbourg France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号